Patents Assigned to Genebiology, Inc.
  • Injectable meclizine formulations and methods
    Patent number: 8293749
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: October 23, 2012
    Assignee: Genebiology, Inc.
    Inventors: Walker Anderson Long, Edwin Curran Murphy, III
  • Injectable meclizine formulations and methods
    Patent number: 8138192
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: March 20, 2012
    Assignee: Genebiology, Inc.
    Inventors: Walker Anderson Long, Edwin Curran Murphy, III